Is Nucleus Software Exports Ltd (NUCLEUS) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nucleus Software Exports Ltd is a good quality company .

Is Nucleus Software Exports Ltd (NUCLEUS) undervalued or overvalued?

The key valuation ratios of Nucleus Software Exports Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Nucleus Software Exports Ltd (NUCLEUS) share price return in the past 10 years?

Nucleus Software Exports Ltd share price has appreciated 15.4% annually (CAGR) over the past ten years.

Is Nucleus Software Exports Ltd (NUCLEUS) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Nucleus Software Exports Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Nucleus Software Exports Ltd (NUCLEUS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Nucleus Software Exports Ltd (NUCLEUS) on 10-Apr-2026 16:59:59 at 16:59 is 811.95.

What is the market cap of Nucleus Software Exports Ltd (NUCLEUS)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Apr-2026 at 16:59, the market cap of Nucleus Software Exports stood at Rs. 2137.48 Cr.

What is the P/E ratio of Nucleus Software Exports?

The latest standalone P/E ratio of Nucleus Software Exports as of 10-Apr-2026 is 14.44.

What is the P/B ratio of Nucleus Software Exports Ltd (NUCLEUS)?

The latest standalone P/B ratio of Nucleus Software Exports Ltd (NUCLEUS) as of 10-Apr-2026 is 2.55.

What is the 52-week high and low of Nucleus Software Exports Ltd (NUCLEUS)?

The 52-week high of Nucleus Software Exports Ltd (NUCLEUS) is Rs. 1375.75 and the 52-week low is Rs. 716.00.

What is the TTM revenue of Nucleus Software Exports Ltd (NUCLEUS)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nucleus Software Exports is Rs. 812.08 (Cr.).

Nucleus Software Exports Ltd (NUCLEUS) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Nucleus Software Exports Ltd (NUCLEUS)
Brand: Nucleus Software Exports

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	13%	12.5%	17.1%	21.1%	25.7%	24.8%	10.3%	33%	37.4%	28.2%	-
Value Creation Index ⓘ	-0.1	-0.1	0.2	0.5	0.8	0.8	-0.3	1.4	1.7	1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	278	299	337	397	444	454	448	585	766	769	812
Sales YoY Gr.	-	7.6%	12.7%	17.6%	12%	2.3%	-1.4%	30.5%	31%	0.3%	-
Adj EPS ⓘ	14.2	16	22.6	25.8	33.2	33.8	10.3	42.4	60.9	51.2	56.2
YoY Gr.	-	12.8%	41.1%	14.2%	28.7%	1.8%	-69.4%	309.8%	43.7%	-15.9%	-
BVPS (₹) ⓘ	130.8	151.5	144.6	161.9	186.6	222.8	175.3	219.6	279.8	297.5	318.8
Adj Net Profit ⓘ	45.9	51.8	65.6	74.9	96.4	98.2	27.7	113	163	135	148
Cash Flow from Ops. ⓘ	11.5	80.9	67.9	37.7	69.1	106	56.4	51.9	212	139	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12%	11.6%	19.7%	0.3%
Adj EPS ⓘ	15.3%	9.1%	70.5%	-15.9%
BVPSⓘ	9.6%	9.8%	19.3%	6.3%
Share Price	15.4%	8.8%	8.7%	0.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	11.2	11.3	14.4	16.8	19.1	16.5	5	21.5	24.4	17.6	18.3
Op. Profit Mgn % ⓘ	5.7	11.9	12.7	15.3	17.4	26.1	8.1	26.9	27.9	20.8	18.9
Net Profit Mgn % ⓘ	16.5	17.3	19.4	18.9	21.7	21.6	6.2	19.4	21.3	17.5	18.2
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	247	190	141	114	96	109	111	111	130	150	108
Cash Conv. Cycle ⓘ	67	41	14	25	43	46	51	64	65	57	44

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 19.71%

Net Profit is growing at healthy rate in last 3 years 70.48%

Return on Equity has declined versus last 3 years average to 18.30%

Sales growth is not so good in last 4 quarters at 8.45%

	Standalone	Consolidated
TTM EPS (₹)	56.2	55.8
TTM Sales (₹ Cr.)	812	880
BVPS (₹) ⓘ	318.8	330.3
Reserves (₹ Cr.) ⓘ	813	843
P/BV ⓘ	2.55	2.46
PE ⓘ	14.44	14.54

From the Market
52 Week Low / High (₹)	716.00 / 1375.75
All Time Low / High (₹)	1.42 / 1830.00
Market Cap (₹ Cr.)	2,137
Equity (₹ Cr.)	26.3
Face Value (₹)	10
Industry PE ⓘ	23

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	278	299	337	397	444	454	448	585	766	769
Operating Expenses > ⓘ +	265	264	295	339	367	336	412	428	553	609
Manufacturing Costs	24	19	21	24	30	9	10	16	23	27
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	164	176	216	247	267	277	336	338	427	472
Other Costs > ⓘ	77	69	58	68	71	50	66	73	102	109
Operating Profit > ⓘ	13	35	43	58	77	118	36	157	214	160
Operating Profit Margin (%)	4.7%	11.7%	12.7%	14.5%	17.4%	26.1%	8.1%	26.9%	27.9%	20.8%
Other Income > ⓘ +	51	32	42	43	64	40	34	34	49	70
Exceptional Items > ⓘ	0	0	0	0	0	0	0	0	0	0
Interest > ⓘ	0	0	0	0	1	1	0	1	1	1
Depreciation > ⓘ	11	10	6	7	11	11	13	17	13	14
Profit Before Tax > ⓘ	53	57	78	94	129	147	57	173	249	216
Tax > ⓘ	8	5	12	18	27	34	15	43	63	54
Profit After Tax	45	52	66	76	102	112	42	130	186	162
PAT Margin (%)	16.1%	17.3%	19.5%	19.1%	23.0%	24.7%	9.4%	22.3%	24.3%	21.0%
Adjusted EPS (₹)	13.8	16.0	22.6	26.0	35.2	38.6	15.7	48.7	69.5	61.4
Dividend Payout Ratio (%)	36%	31%	35%	35%	26%	23%	45%	21%	18%	20%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	424	491	420	470	542	647	469	588	749	783
Share Capital ⓘ	32	32	29	29	29	29	27	27	27	26
Reserves ⓘ	392	458	391	441	513	618	443	561	722	757
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	28	29	51	10	18	14	11	11	18	15
Others Liabilities ⓘ	124	110	140	144	170	190	219	241	304	312
Total Liabilities ⓘ	577	630	611	624	730	850	700	840	1,072	1,110
Fixed Assets
Net Fixed Assets ⓘ +	35	30	31	32	41	32	43	36	45	48
Gross Block	118	40	47	55	72	71	92	99	114	128
Accumulated Depreciation	83	10	16	23	31	39	49	63	70	81
CWIP ⓘ	1	0	0	0	0	1	0	1	1	0
Investments ⓘ	253	447	394	433	489	649	494	540	664	656
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	78	53	68	61	80	81	76	165	157	129
Cash Equivalents	93	33	46	52	74	24	35	33	46	91
Others Assets ⓘ	116	66	73	46	46	64	51	65	159	187
Total Assets ⓘ	577	630	611	624	730	850	700	840	1,072	1,110

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	12	81	68	38	69	106	56	52	212	139
PBT ⓘ	53	57	78	94	129	147	57	173	249	216
Adjustment ⓘ	-34	-13	-33	-24	-44	-22	-14	-7	-30	-53
Changes in Working Capital ⓘ	1	48	39	-12	4	11	28	-88	67	14
Tax Paid ⓘ	-8	-10	-16	-19	-20	-30	-15	-27	-75	-38
Cash Flow From Investing Activity ⓘ +	17	-74	74	-18	-10	-126	159	-13	-197	-13
Capex	-5	-4	-7	-8	-12	-3	-24	-4	-28	-15
Net Investments	-80	-168	65	-33	-35	-134	165	-18	-162	-5
Others ⓘ	102	97	16	23	36	11	18	9	-7	7
Cash Flow From Financing Activity ⓘ +	-34	0	-134	-25	-32	-11	-211	-21	-29	-125
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	-0	-0	-0	-1	-0	-0
Dividend Paid ⓘ	-34	0	-17	-25	-29	-9	-17	-19	-27	-33
Others ⓘ	0	0	-117	0	-2	-2	-193	-2	-2	-91
Net Cash Flow ⓘ	-6	7	8	-5	27	-31	4	17	-15	0

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	10.92	11.33	14.41	17	20.2	18.85	7.54	24.66	27.82	21.11
ROCE (%)	13	12.49	17.13	21.08	25.65	24.78	10.26	32.95	37.37	28.23
Asset Turnover Ratio	0.49	0.5	0.54	0.64	0.66	0.57	0.58	0.76	0.8	0.7
PAT to CFO Conversion(x)	0.27	1.56	1.03	0.5	0.68	0.95	1.33	0.4	1.14	0.86
Working Capital Days
Receivable Days	102	80	66	59	58	65	64	75	77	68
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

About Nucleus Software Exports Ltd

Nucleus Software Exports provides innovative and pioneering products and software solutions since 1986. It provides software solutions to the Banking, Financial Services Industry (BFSI). For over 20 years, it has developed solutions spanning from retail banking to corporate banking, cash management, internet banking and credit cards. FinnOne, the flagship product of Nucleus Software is a comprehensive suite for retail banking applications comprising modules like customer acquisition system, loan management, delinquency and recovery management, deposits and finance against securities.

Products of the company

Customer Acquisition System
Loan Management System
Collections
General Ledger
Forecaster
Finance against Securities
Lead Management System
Customer Service Module
Power Pay
Collateral Management System
Central Liability System
Web based Islamic Financing Product

Milestones/ Awards

2014
Nucleus Software win The Asian Banker Technology Implementation Awards 2014 for ""Best Lending Platform Implementation.
Nucleus Software Exports Ltd won the Best Corporate Governance - India - 2014.
2012
Nucleus Software's FinnOne Ranked Best Selling Lending Solution across the Globe.
Nucleus Software ranked the Best for Online Annual Report by IR Global Rankings
2011
Nucleus Software wins Gold shield for Excellence in financial Reporting , 2010 by Institute of Chartered Accountants of India (ICAI)".
"Nucleus Software's FinnOne is World's No. 1 Leading Software for the Third Consecutive Year"
"Nucleus Software Ranked Amongst Top 5 Indian Companies for Corporate Governance"
2009 - Good Corporate Governance Practices
2009 - SAFA - Best Presented Accounts Award 2008
2009 - Celent 2009 Model Bank Award
2009 - FinnOne - World's No 1 Selling Lending Software product
2008 - Amongst India's Top 15 Exciting Emerging Companies to Work For
2008 - Asia's 200 Best Under A Billion Companies
2008 - Good Corporate Governance Practices
2008 - D&B â€“ ECGC Indian Exportersâ€™ Excellence Award
2008 - FinnOne- World's 2nd Best Selling Lending Software product
2007 - FinnOne - World's No 1 Selling Lending Software product
2006 - Excellence in Financial Reporting
2005 - Asia Pacific Level Technology Award
2004 - Global Banking Back Office Systems
2004 - Most Innovative ISV
2003 - Building World Class Loan Management Solution
2002 - 15th Highest selling Back Office Banking System Product

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Nucleus Software Exports Ltd (NUCLEUS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Nucleus Software Exp Share Price